Nayzilam 5 mg/0.1 mL single-dose nasal spray unit Images
Generic Name: midazolam
This medication has been identified as Nayzilam 5 mg/0.1 mL single-dose nasal spray unit. It is supplied by UCB, Inc.
Nayzilam is used in the treatment of Seizures and belongs to the drug class benzodiazepines. There is positive evidence of human fetal risk during pregnancy. Nayzilam 5 mg/0.1 mL single-dose nasal spray unit is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images of medication
Nayzilam
- Generic Name
- midazolam
- Strength
- 5 mg/0.1 mL single-dose nasal spray unit
- Availability
- Prescription only
- Drug Class
- Benzodiazepines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- UCB, Inc.
- National Drug Code (NDC)
- 50474-0500
More about Nayzilam (midazolam)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: benzodiazepines
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
